Bankers Trust’s Merck MRK Stock Holding History

Bankers Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.45M	Buy	26,175 +89	+0.3%	+$4.86K	0.87%	48
2014 Q1	$1.41M	Buy	26,086 +1,400	+6%	+$72.5K	0.91%	47
2013 Q4	$1.18M	Buy	24,686 +872	+4%	+$39.9K	0.73%	57
2013 Q3	$1.08M	Buy	23,814 +686	+3%	+$31.3K	0.76%	55
2013 Q2	$1.03M	Buy	+23,128	New	+$1.03M	0.77%	55

Other funds holding MRK

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bankers Trust's MRK Position: Q2 2014 in Review

Bankers Trust increased its Merck (MRK) stake by 0.34% in Q2 2014, buying an estimated $4.86K and bringing the position to 26,175 shares worth $1.45M. The position accounts for 0.87% of the portfolio, ranked #48.

Bankers Trust first reported a position in MRK in Q2 2013 and has held it in 5 quarters since. 1,621 funds tracked by Wall St. Rank hold MRK as of Q2 2014.

Bankers Trust held 26,175 shares of Merck worth $1.45M as of Q2 2014.
Bankers Trust bought 89 Merck shares in Q2 2014, an estimated $4.86K.
Merck made up 0.87% of Bankers Trust's portfolio in Q2 2014, its #48 holding.
Bankers Trust first reported a position in Merck in Q2 2013 and has held it in 5 quarters since.
1,621 funds tracked by Wall St. Rank held Merck as of Q2 2014.

Based on Bankers Trust's 13F filing for Q2 2014, filed 15 Aug 2014.